Chevron's EV Charging Bet, Psychedelic Depression Treatment, and Electric Boats

Oil Giant Chevron Wants in on EV Charging Stations

Chevron Technology Ventures has backed Electric Era’s $11.5 million Series A funding round. The company is building high speed EV charging infrastructure that they aim to integrate at gas stations and convenience stores across the United States.

Esketamine is Disrupting Traditional Depression Treatments

Spravato, Johnson & Johnson’s FDA-approved medicine that contains the psychedelic drug esketamine, is showing signs of being more effective for treatment resistant depression than traditional antidepressant medications.

Silicon Valley is Backing Electric Boats

Arc has raised a $70 million Series B round that includes some of Silicon Valley’s most prominent investors, including a16z, Lowercarbon Capital, Abstract Ventures, and Menlo Ventures.

The Sprint

• Pfizer has funded VitaDAO, an organization bringing biotech investment to the blockchain.

• Bill Gates is backing a space startup that is working on reusable rockets that can fly daily.

• Machina Labs landed an investment from Nvidia to build the next generation of AI-powered manufacturing robots.

• Solar energy currently accounts for 14% of the world’s silver demand, and is on the rise alongside the push for net zero.

Trending Now

• Sam Altman is Backing This Blood Testing Startup

• The Company Treating ADHD With a Video Game

• The Next Era for Psychedelic Companies